IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN (VOL 68, PG 7340, 1994)

被引：5

作者：

CULMANNPENCIOLELLI, B

LAMHAMEDICHERRADI, S

COUILLIN, I

GUEGAN, N

LEVY, JP

GUILLET, JG

GOMARD, E

机构：

来源：

JOURNAL OF VIROLOGY | 1995年 / 69卷 / 01期

关键词：

D O I：

10.1128/JVI.69.1.618-618.1995

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：618 / 618

页数：1

共 50 条

[41] ABERRANT GAG PROTEIN-COMPOSITION OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF MUTANT - PRODUCED IN PRIMARY LYMPHOCYTES
SIMM, M
SHAHABUDDIN, M
CHAO, W
ALLAN, JS
VOLSKY, DJ
JOURNAL OF VIROLOGY, 1995, 69 (07) : 4582 - 4586
[42] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN INHIBITS ACTIVATION PATHWAYS IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AND T-CELL LINES
GREENWAY, A
AZAD, A
MCPHEE, D
JOURNAL OF VIROLOGY, 1995, 69 (03) : 1842 - 1850
[43] AUGMENTATION OF VIRUS SECRETION BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPU PROTEIN IS CELL-TYPE INDEPENDENT AND OCCURS IN CULTURED HUMAN PRIMARY MACROPHAGES AND LYMPHOCYTES
SCHUBERT, U
CLOUSE, KA
STREBEL, K
JOURNAL OF VIROLOGY, 1995, 69 (12) : 7699 - 7711
[44] HIGHLY LOCALIZED TRACKS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF IN THE NUCLEUS OF CELLS OF A HUMAN CD4+ T-CELL LINE
MURTI, KG
BROWN, PS
RATNER, L
GARCIA, JV
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) : 11895 - 11899
[45] HUMAN CD4+ CYTOLYTIC T-LYMPHOCYTE RESPONSES TO A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP160 SUBUNIT VACCINE
STANHOPE, PE
CLEMENTS, ML
SILICIANO, RF
JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (01): : 92 - 100
[46] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIGENEMIA IS ENHANCED IN PATIENTS WITH DISSEMINATED CYTOMEGALOVIRUS-INFECTION AND DEFICIENT LYMPHOCYTES-T
FIALA, M
CONE, LA
CHRISTOPHER, R
KERMANI, V
GORNBEIN, JA
RESEARCH IN IMMUNOLOGY, 1991, 142 (09): : 815 - 819
[47] A REV-INDUCIBLE MUTANT GAG GENE STABLY TRANSFERRED INTO T-LYMPHOCYTES - AN APPROACH TO GENE-THERAPY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
SMYTHE, JA
SUN, D
THOMSON, M
MARKHAM, PD
REITZ, MS
GALLO, RC
LISZIEWICZ, J
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (09) : 3657 - 3661
[48] IDENTIFICATION AND CHARACTERIZATION OF A HUMAN HERPESVIRUS-6 GENE SEGMENT CAPABLE OF TRANSACTIVATING THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT IN AN SP1 BINDING SITE-DEPENDENT MANNER (VOL 68, PG 1707, 1994)
WANG, JH
JONES, C
NORCROSS, M
BOHNLEIN, E
RAZZAQUE, A
JOURNAL OF VIROLOGY, 1994, 68 (06) : 4108 - 4108
[49] LOSS OF CD4 T-LYMPHOCYTES IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IS MORE PRONOUNCED IN THE DUODENAL MUCOSA THAN IN THE PERIPHERAL-BLOOD
SCHNEIDER, T
JAHN, HU
SCHMIDT, W
RIECKEN, EO
ZEITZ, M
ULLRICH, R
GUT, 1995, 37 (04) : 524 - 529
[50] CROSS-REACTIVE CYTOTOXIC T-LYMPHOCYTES INDUCED BY V3 LOOP SYNTHETIC PEPTIDES FROM DIFFERENT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
CASEMENT, KS
NEHETE, PN
ARLINGHAUS, RB
SASTRY, KJ
VIROLOGY, 1995, 211 (01) : 261 - 267

← 1 2 3 4 5 →